Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results

Go back to Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
(NASDAQ: VRCA) Delayed: 5.50 +0.11 (2.04%)
Previous Close $5.39    52 Week High
Open $5.48    52 Week Low
Day High $5.50    P/E N/A 
Day Low $5.48    EPS
Volume 3,582